Clinical trial
Use of High Sensitivity Cardiac Troponin in Safely Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction (SAFETY)
NCT04280926 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of High Sensitivity Cardiac Troponin in Safely Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction (SAFETY)
- Lead sponsor
- Hennepin Healthcare Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 13, 2020
- Completion date
- October 13, 2024
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, acute myocardial infarction